Akari Therapeutics Plc
AKTX$15.71▲ 4.84% 24h
Akari Therapeutics PlcAKTX$15.71
-$1.81(-10.35%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$1.44T
P/E ratio
—
EPS (diluted)
$0.00
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$0
Net income
$-17.30M
Net margin
—
Gross margin
—
Dividends & financials
Akari Therapeutics Plc (AKTX) reported revenue of $0 and net income of $-17.30M, or $0.00 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.